Dr. Russell Butterfield is a clinician scientist focused on translational research in neuromuscular disorders. He received his PhD in genetics, and medical degree from the University of Illinois. He completed his residency training in pediatric neurology and fellowship in neuromuscular disorders at the University of Utah. He is currently an Associate Professor in the Departments of Pediatrics and Neurology at the University of Utah where he directs the Muscular Dystrophy Clinic at the University of Utah and Neuromuscular Clinic at Primary Children’s Hospital. Dr Butterfield leads a translational research program through the Utah Program in Inherited Neuromuscular Disorders (UPIN) that includes clinical and basic research studies. Dr. Butterfield’s research is focused on implementation of genetic therapies and understanding genetic modifiers of severity in various types of muscular dystrophy including Duchenne muscular dystrophy, FSHD, and collagen VI-related muscular dystrophies.
Cure Rare Disease, a non-profit organization (Tax ID number 82-2473513), is qualified as a tax-exempt organization under section 501(c)(3) of the IRS and has been designated as a “public charity” under section 170.
© CURE RARE DISEASE. ALL RIGHTS RESERVED.
.png)
© CURE RARE DISEASE.ALL RIGHTS RESERVED.
